Article
Risk Factors for Septic Shock After Irinotecan-Containing Chemotherapy: An Exploratory Case-Control Study.
Drugs in R&D - 1 Dec 2022
Umemiya Maki, Inayama Yoshihide, Nakatani Eiji, Ito Kenta, Tsuji Mitsuru, Yoshida Teruki, Yu Sae, Gou Rei, Horikawa Naoki, Tani Hirohiko, Kosaka Kenzo
Abstract excerpt
BACKGROUND AND OBJECTIVES: Irinotecan sometimes causes lethal septic shock but the risk factors remain unclear. This retrospective case-control study explored the potential risk factors for septic shock following irinotecan treatment. METHODS: All women who received irinotecan-containing chemotherapy for gynecologic malignancies at Shizuoka General Hospital from October 2014 to September 2020 were investigated....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
